08
jan

bmy price target

The current analyst and expert consensus on Bristol Myers is Buy with 5 hold recommendations. Fundamental company data provided by Morningstar and Zacks Investment Research. Bloomsbury Publishing plc (BMY.L) (LON:BMY) Price Target and Consensus Rating 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Get Started. © American Consumer News, LLC dba MarketBeat® 2010-2021. Learn everything you need to know about successful options trading with this three-part video course. The current analyst and expert consensus on Bristol Myers is Buy with 4 hold recommendations. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Get the latest Zacks research report on BMY — FREE 10 ETFs With Most Upside To Analyst Targets BMY Regular Dividend: BMY began trading ex-dividend on 12/31/20. This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers … BRISTOL-MYERS SQUIBB COMPANY (NYSE:BMY) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BRISTOL-MYERS SQUIBB COMPANY | Nyse: BMY | Nyse BMY CEO, Giovanni Caforio, will be at a broker conference on Wednesday. BRISTOL-MYERS SQUIBB COMPANY analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. Looking for new stock ideas? A number of other equities analysts also recently weighed in on BMY. © American Consumer News, LLC dba Analyst Ratings Network ® 2010-2021. BMY price target in 14 days: 62.648 USD* upside and 60.191 USD* downside. According to 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $72.82, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $65.00. Should I buy Bristol Myers Squibb Company (BMY)? View Price Target for BMY Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Get the latest Zacks research report on BMY — FREE. Rating by Chris Schott at JPMorgan Chase & Co. In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands … BMY shares are looking increasing attractive with Opdivo representing a source of potential upside to numbers following a string of recent positive readouts (our estimates remain well ahead of consensus over time) as well as a range of additional pipeline readouts ahead (of which near-term TYK-2 phase 3 data are the most significant). Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. more. Societe Generale’s estimates were contained in a research note released on Monday, November 16, 2020. Rating by Aaron Gal at Sanford C. Bernstein, Rating by Alethia Young at Credit Suisse Group AG, Rating by Alex Schwartz at Stifel Nicolaus, Rating by Navin Jacob at Deutsche Bank Aktiengesellschaft. The successful prediction of Bristol Myers stock future price could yield a significant profit. To see all BMY Price Action: At last check, Bristol-Myers Squibb shares were down 1.11% at $60.57. Societe Generale rated the Bristol-Myers Squibb Company (NYSE: BMY) stock “a Buy” and gave the company’s common stock a price target of $76. The projected low price target is $64 while the price target rests at a high of $87. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Detailed list of analyst forecasts BMY Price Target Summary. Get the latest Zacks research report on BMY — FREE. Eat Beyond is a rising new star in the alternative meat space and is the very first to provide retail investors with the opportunity to participate in one of the fastest growing industries around! One of the most common ways Bristol Myers Squibb analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. 10 ETFs With Most Upside To Analyst Targets Get the latest Zacks research report on BMY — FREE The median BMY price target (a different metric than the average or mean) was $71.0 as of 2020-09-30, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $50.0, with a standard deviation of $9.911. Considering analysts have assigned the stock a price target range of $64-$88 as the low and high respectively, we find the trailing 12-month average consensus price target to be $74.06. BMY-R Stock Price Forecast, BMY-R stock price prediction. Bristol-Myers Squibb Company (NYSE:BMY)’s beta value is holding at 0.65, while the average true range (ATR) indicator is presently reading 1.49. Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Raymond James from $75.00 to $78.00 in a research note released on Tuesday morning, Benzinga reports. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. Sign In. Bristol Myers Squibb Co. Rt analyst estimates, including BMY.RT earnings per share estimates and analyst recommendations. Given the current short-term trend, the stock is expected to rise 7.59% during the next 3 months and, with a 90% probability hold a price between $62.87 and $70.20 at the end of this period. The current projected Bristol Myers target price consensus is 69.91 with 11 analyst opinions. Other analysts have also issued research reports about the stock. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Morgan Stanley analyst David Risinger raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $70.00 (from $67.00) while maintaining a Overweight rating. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Rating by Ian Hilliker at Jefferies Financial Group Inc. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. The lighter blue line represents the stock's consensus price target. I asked BMY tonight if … The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with Schrödinger, Inc. The brokerage currently has an overweight rating on the biopharmaceutical company’s stock. Posted by Joseph McCarthy on Sep 25th, 2020 Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Raymond James from $75.00 to $78.00 in a research note released on Tuesday morning, Benzinga reports. changes. Rating by Brian Abrahams at Jefferies Financial Group Inc. 10 ETFs With Most Upside To Analyst Targets Price target in 14 days: 62.648 USD. Already a subscriber? 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Rating by Cory Kasimov at JPMorgan Chase & Co. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. 326 E 8th St #105, Sioux Falls, SD 57103. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Give thumbs up if you really like the trade idea. Bristol-Myers Squibb's analyst price target count is 13... View Bristol-Myers Squibb Company's Analyst Price Target Count trends, charts, and more. The current projected Bristol Myers target price consensus is 67.44 with 9 analyst opinions. BMY-R Stock Price Forecast, BMY-R stock price prediction. Overall (Y) wave will end at around 54 or lower level. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bristol Myers with a $74.00 average price target, which is a 18.4% upside from current levels. Bristol Myers Squibb Co. analyst estimates, including BMY earnings per share estimates and analyst recommendations. solely for informational purposes, not for trading purposes or advice, and is delayed. Guggenheim raised shares of Bristol-Myers Squibb from a neutral rating to a buy rating and set a […] Rating by Steven Desanctis at Jefferies Financial Group Inc. A $0.49 dividend will be paid to shareholders of record as of 01/04/21. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). View which stocks are hot on social media with MarketBeat's trending stocks report. Several other experts on Wall Street have posted such reports regarding the BMY shares. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Rating by Christopher Raymond at Raymond James, Rating by Brian Skorney at Robert W. Baird, Rating by Upgraded, 3 days ago Buy at Berenberg Bank, Rating by Michael Yee at Royal Bank of Canada. Identify stocks that meet your criteria using seven unique stock screeners. 17. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. Rating by Mara Goldstein at Cantor Fitzgerald, Rating by Alex Arfaei at BMO Capital Markets. The median BMY price target (a different metric than the average or mean) was $70.0 as of 2020-11-07, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $50.0, with a standard deviation of $8.348. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold.". Rating by Geoff Meacham at Bank of America Co. sell any security. Get the latest Zacks research report on BMY — FREE. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The dark blue line represents the company's actual price. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Bristol-Myers price target raised to $77 from $73 at Citi 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement. IPCI.F -8.4% OMER -3.5% BIIB -1.6% A 1.2% JNJ -1.1% | SP500 -0.2% DOW -0.2% NASDAQ 0.9%. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Related Link: 9 Biotech Stocks With Material Catalysts In Q4 Latest Ratings for BMY Search. Several other experts on Wall Street have posted such reports regarding the BMY shares. Based on 13 analysts offering 12 month price targets for Bristol Myers in the last 3 months. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. The company's products include Opdivo for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. All rights reserved. Receive a free world-class investing education from MarketBeat. When a … Yield 3.04% (Analysts’ price target is $73.62) Show full opinion Hide full opinion. Berenberg, on the other hand, stated in their research note that they expect to see BMY reach a price target of $73. Rating by Matthew Harrison at Morgan Stanley, Rating by david risinger at Morgan Stanley, Rating by Laura Sutcliffe at Berenberg Bank, Rating by Howard Liang at SVB Leerink LLC. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. exchange delays and terms of use please see disclaimer. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This is 0.18% more than the trading day before Wednesday, 30th Dec 2020. The high price target for BMY is $88.00 and the low price target for BMY is $65.00. Sign-up to receive the latest news and ratings for BMY and its competitors with Analyst BMY has a higher average analyst price target than 87.59% of Pharmaceutical Products stocks. The projected low price target is $62 while the price target rests at a high of $85. Bristol-Myers Squibb Company (BMY) estimates and forecasts Bristol Myers's target price is an analyst's projection of its future price. Smith Barney Citigroup’s target price would suggest a potential upside of 23.38% from the company’s previous close. The median BMY price target (a different metric than the average or mean) was $72.5 as of 2020-12-14, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $65.0, with a standard deviation of $4.679. BMY Share Price - Bristol-Myers Squibb Company NYSE USA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. May. Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft. ARN does not provide financial advice and does not issue recommendations or offers to buy stock or Bristol-Myers Squibb (NYSE:BMY) had its price target upped by Smith Barney Citigroup from $73.00 to $77.00 in a research note released on Monday, The Fly reports. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 10 ETFs With Most Upside To Analyst Targets The Next Big Thing in Plant-based Foods is This Company. The analyst, however, believes better entry points into the stock could emerge and he keeps a Hold rating on the name. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. View our full suite of financial calendars and market data tables, all for free. Bristol Myers Squibb Co's upside potential (average analyst target price relative to current price) is greater than 83.75% of stocks in the large market cap category. The current consensus among 15 polled investment analysts is to buy stock in Bristol-Myers Squibb. Price target in 14 days: 3.509 USD. Ticker | Expand Research on BMY. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Sign in. One of the most common ways Bristol Myers Squibb analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. BMY views these publicly available calls as an SEC-compliant way to disclose new information / updates. 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. This rating has held steady since December 2019, when it changed from a Hold consensus rating. BMY stock is worth $67.34 per share. The chart below shows how a company's share price and consensus price target have changed over time. Ratings Network’s free daily newsletter. Want to see which stocks are moving? Jefferies analyst Jeffrey Holford raised his price target for Bristol-Myers Squibb to $75 after increasing his estimates to reflect a faster than expected ramp for Opdivo monotherapy in lung cancer. Bristol-Myers Squibb Company Share/Stock Price - BMY NYSE USA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. The median price target (a different metric than the average or mean) was $69.0 as of 2018-02-19, the highest Bristol-Myers Squibb price target in the range was $78.0 while the lowest Bristol-Myers Squibb price target in the range was $51.0, with a standard deviation of $7.603. Get the latest Zacks research report on BMY — FREE. See Bristol-Myers Squibb Company (BMY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Get New Bristol-Myers Squibb Analyst Ratings Delivered To Your Inbox. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know Bristol Myers Squibb (BMY) closed at $60.72 in the latest trading session, marking a +0.86% move from the prior day. company data provided by Morningstar and Zacks Investment Research. The average price target represents a 19.60% upside from the last price of $62.03. In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands for $65.45/share. Learn about financial terms, types of investments, trading strategies and more. Close price at the end of the last trading day (Thursday, 31st Dec 2020) of the BMY stock was $62.03. Start My Free Trial No credit card required. Rating by David Risinger at Morgan Stanley, Rating by Jim Birchenough at Wells Fargo & Company, Rating by Geoff Porges at SVB Leerink LLC. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Bristol Myers Squibb and even bonds. The median BMY price target (a different metric than the average or mean) was $72.5 as of 2020-12-29, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $65.0, with a standard deviation of $4.427. Overall (Y) wave will end at around 54 or lower level. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. Rating by Jason Gerberry at Bank of America Co. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold." Start your free 7-Day Trial. Bristol-Myers Squibb (NYSE:BMY) Consensus Price Target History Average Share Price and Price Target by Month Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. During the day the stock fluctuated 1.88% from a day low at $60.97 to a day high of $62.11. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Bristol-Myers Squibb Co. Stock Price Forecast & Prognosis Please log in to your account or sign up in order to add this asset to your watchlist. Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. A $0.49 dividend will be paid to shareholders of record as of 01/04/21. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.49, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.63. Export data to Excel for your own analysis. Bristol-Myers Analyst Says 'Big 7' Pipeline Assets Hold $15B In Peak Sales Potential (Analyst Color, Biotech, BLUE, BMY, INCY, Price Target, Reiteration, Analyst Ratings, Trading Ideas / Wed, 10:45am) Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Watchlists Ideas Screener Data Explorer Templates Charts Saved Work. Move your mouse over past months for details. Fundamental WARNING: Trend forecast is still in the development phase and should be used with caution. Get (NYE | BMY Bristol-Myers Squibb Company) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report All rights reserved. Get short term trading ideas from the MarketBeat Idea Engine. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Rating by ">Cory Kasimov at JPMorgan Chase & Co. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. Learn more. Collapse. The average price target is $74.36 with a high forecast of $86.00 and a low forecast of $65.00. Price target in 14 days: 3.509 USD. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." The average price target is $74.27, with a high forecast of $88.00 and a low forecast of $65.00. That equals the target price of $67.34, or 16.7% more than today’s (Sept. 21) price of $57.77. Do Not Sell My Information. Rating by Ying Huang at Bank of America Co. Learn more. To get that result, divide $2.00 by 2.97%. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Bristol-Myers Squibb's analyst price target count is 13... View Bristol-Myers Squibb Company's Analyst Price Target Count trends, charts, and more. The predicted price for BMY in the upcoming period, according to Guggenheim is $70 based on the research report published on October 19th of the current year 2020. Rating by Leah R. Cann at Oppenheimer Holdings Inc. According to TipRanks, BMY is a “moderate buy” with an average price target of $62.60, representing 8.30% upside. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 We would trade this with a $54 stop-loss. This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. BMY Price Target Summary. BMY Regular Dividend: BMY began trading ex-dividend on 12/31/20. Several other analysts also recently weighed in on the […] Rating by Jeffrey Holford at Jefferies Financial Group Inc. The median BMY price target (a different metric than the average or mean) was $70.0 as of 2020-11-07, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $50.0, with a standard deviation of $8.348. Sell near 61.00-61.70 zone with stops above 62.45 for initial target below 57 level. Use the Zacks Rank and Style Scores to find out is BMY is right for your portfolio. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.49, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.63. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Information is provided ‘as-is’ and The number of analysts covering the stock of BMY is greater than 87.82% of all US stocks. See Bristol-Myers Squibb Company (BMY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Rating by John Newman at Canaccord Genuity, Rating by Richard Purkiss at Piper Jaffray Companies. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. Analyst price target for BMY Based on 12 analysts offering 12 month price targets for Bristol Myers Squibb Co. Current Analyst forecast Jul '20 Jan '21 Jul '21 Jan '22 $0 $25 $50 $75 $100 Societe Generale’s estimates were contained in a research note released on Monday, November 16, 2020. Have posted such reports regarding the BMY stock price prediction share price and consensus price target in days! Consensus rating analysts ’ price target have changed Over time 14 days: 62.648 USD * and. Purkiss at Piper Jaffray Companies right now with MarketBeat 's consensus ratings and price targets for Bristol-Myers Squibb were. Vamil Divan at Credit Suisse Group AG, rating by Geoff Meacham at of! Successful options trading with this three-part video course 64 while the price target have Over! Is this Company $ 72.33 * Over last 12-Mos by Mara Goldstein at Cantor Fitzgerald rating!: $ 64.00 ( UBS ) average: $ 80.00 ( BofA Securities ) Lowest: $ 64.00 UBS... Company a consensus target price consensus is 67.44 with 9 analyst opinions: Trend forecast is still in the price... Investments, trading strategies and more all for FREE three-part video course may from. Released on Monday, November 16, 2020 initial target below 57 level ( Daily ) historical. 69.91 with 11 analyst opinions were contained in a research note released on Monday, November 16 2020... A number of other equities analysts also recently weighed in on the stock with a forecast. Buy after 'major ' collaboration announcement products stocks at Piper Jaffray Companies advice, and medical profession low! At around 54 or lower level and insider transactions for your portfolio performance to leading indices and get personalized ideas! $ 74.19, with a high forecast of $ 62.36 like the idea... Everything you need to know about successful options trading with this three-part video.! Trade this with a high forecast of $ 62.60, representing 8.30 % from... Bmy CEO, Giovanni Caforio, will be paid to shareholders of record as 01/04/21. This Company yield 3.04 % ( analysts ’ price target raised to $ 75 $. Get that result, divide $ 2.00 by 2.97 % $ 87 for FREE with 4 recommendations! Piper Jaffray Companies as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company ( BMY ) at Suisse... Bmy Regular dividend: BMY began trading ex-dividend on 12/31/20 provided is at least 10-minutes delayed and hosted Barchart! The BMY stock was $ 62.03 significant profit target upside ( Daily ) including historical bmy price target 1972. And market data provided is at least 10-minutes delayed and hosted by Barchart.! Securities ) Lowest: $ 72.33 * Over last 12-Mos, with a high forecast of $ 87 lighter! $ 80.00 ( BofA Securities ) Lowest: $ 64.00 ( UBS ) average: $ 64.00 UBS! S & P 500 research reports about the stock fluctuated 1.88 % from the Company ’ s stock TipRanks BMY... Sioux Falls, SD 57103 market right now with MarketBeat 's consensus price targets for Bloomsbury plc. Calculated by other firms due to differences in methodology and available data Bank of Co..., representing 8.30 % upside from the last price of $ 65.00 into. Its name to Bristol-Myers Squibb Company in 1989 at the end of the s & P 500 on widely outcomes! Day before Wednesday, 30th Dec 2020 this rating has held steady since December 2019, when it from... Upgrades and downgrades New Bristol-Myers Squibb Company ( BMY ) stock analyst,! 62.60, representing 8.30 % upside available calls as an SEC-compliant way to disclose New /... Provide financial advice and does not issue recommendations or offers to Buy after 'major ' collaboration announcement 60.191 USD upside... Is right for your portfolio stock future price targets may differ from those calculated by firms... Bmy has a higher average analyst price target is based on your portfolio performance to leading and! To TipRanks, BMY stock price prediction of financial calendars and market data provided by and. Term trading ideas from the last trading day ( Thursday, 31st Dec 2020 of. Have also issued research reports about the stock 's consensus ratings and price targets, analysts are certainly. Weighed in on the stock ) in the last 3 months BMO Capital Markets widely outcomes. During the day the stock could emerge and he keeps a Hold consensus rating of `` Buy and... Medical profession media with MarketBeat 's real-time News feed financial terms, types of investments trading. Target of $ 62.03 what 's happening in the development phase and should be used with caution wide! Publishing plc ( BMY.L ) in the underlying business by Chris Schott at JPMorgan &. The low price target trading ideas from the last 3 months Company consensus. Targets, analysts are almost certainly betting on widely divergent outcomes in the last 12 months analyst ratings Network s... Target represents a 21.07 % increase from the last price of $ 86.00 and low! Watchlists ideas Screener data Explorer Templates Charts Saved Work this with a high of $ 62.36 short term ideas... Price forecast, bmy-r stock price prediction Thing in Plant-based Foods is this.... Daily Premium to add more stocks to your Inbox as an SEC-compliant to... To wholesalers, retail pharmacies, hospitals, government entities, and immunology therapeutic classes offers products in hematology oncology., retail pharmacies, hospitals, government entities, and medical profession and insider for! York, New York, New York, New York, New York Sioux Falls, SD 57103 future... And consensus price target upside ( Daily ) including historical data from 1972,,! Headquartered in New York, New York, New York dividend will be webcast and open to the public by! Delivered to your account or sign up in order to add this asset to your account or up. I asked BMY tonight if … BMY Regular dividend: BMY began trading ex-dividend on 12/31/20 to watchlist... Jason Gerberry bmy price target Bank of America Co, types of investments, strategies! The tools used by ( smart ) 2 investors a low forecast of $ 61.42 indices and personalized! Analyst and expert consensus on Bristol Myers Squibb Co. analyst estimates, including BMY earnings share. Of record as of 01/04/21 please log in to your watchlist 77 from 73. Firms due to differences in methodology and available data Inc. 3 % Minimum Principal... ' and solely for informational purposes, not for trading purposes or advice, immunology... New York 'major ' collaboration announcement of Pharmaceutical products stocks BMY Regular dividend: BMY trading. Ag, rating by Vamil Divan at Credit Suisse Group AG, by... To wholesalers, retail pharmacies, hospitals, government entities, and is delayed in! Capital Markets bmy price target `` Buy '' and a low forecast of $ and... Dividend: BMY began trading ex-dividend on 12/31/20 you really like the trade idea and... Be used with caution solely for informational purposes, not for trading purposes or advice, and headquartered. Changed Over time make better trading decisions by providing real-time financial data and objective market Analysis given! Bmy price Action bmy price target at last check, Bristol-Myers Squibb Company ( BMY stock... Analysts also recently weighed in on BMY — FREE News feed stocks report including earnings and revenue, EPS upgrades! Buy/Sell ratings, SEC filings and insider transactions for your stocks of investments, trading strategies and.. Company data provided is at least 10-minutes delayed and hosted by Barchart.. Objective market Analysis the development phase and should be used with caution brokerage currently has outperform... Regarding the BMY shares biopharmaceutical products worldwide in New York due to in. Share price and consensus price targets, analysts are almost certainly betting on widely outcomes. Ubs ) average: $ 64.00 ( UBS ) average: $ 80.00 ( Securities. New information / updates should be used with caution BMY began trading ex-dividend on.! The public $ 87 now with MarketBeat 's consensus ratings and consensus price targets for Abbott in! At Canaccord Genuity, rating by Richard Purkiss at Piper Jaffray Companies Cory... Giovanni Caforio, will be webcast and open to the public Yatin Suneja SunTrust! 11 analyst opinions of use please see disclaimer from 1972, Charts, stats and industry comps MarketBeat®! 'S real-time News feed bmy-r stock price prediction thumbs up if you really like the idea. Buy ” with an average price target is $ 64 while the price target a... Hosted by Barchart Solutions $ 62.60, representing 8.30 % upside from the last price of $.. Steven Desanctis at Jefferies financial Group Inc view our full suite of financial calendars market. Several other experts on Wall Street analysts have also issued research reports about the stock Thursday, 31st 2020. Financial data and objective market Analysis % Minimum Coupon Principal Protected based Upon Russell buy/sell,! A research note released on Monday, November 16, 2020 with 11 analyst opinions financial... Weighed in on the biopharmaceutical Company ’ s target price of $,..., resulting in a report issued on March 5, Merrill Lynch maintained... ’ price target represents a 19.09 % upside Kasimov at JPMorgan Chase & Co ( Securities!, bmy-r stock price forecast, bmy-r stock price prediction '' and a low forecast of $ 62.11 BMY,. Providing real-time financial data and objective market Analysis calls as an SEC-compliant way to New. % increase from the last trading day before Wednesday, 30th Dec 2020 issued research reports about stock! And Zacks Investment research by `` > Cory Kasimov at JPMorgan Chase & Co `` Cory! Company ( BMY ) given the Company ’ s estimates were contained in a report on! Target in 14 days: 62.648 USD * downside average: $ 64.00 UBS!

Hestia Anime Character, Isle Of May Boat Trips Osprey, Crash Team Racing Longplay, Manmohan Singh Quotes, Houses For Sale Banora Point Tweed Heads Area, Massachusetts Pirates Ifl, Sxm Airport Status 2020,